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EPRCytochrome bo3 is the major respiratory oxidase located in the cytoplasmic membrane of Escherichia coli
when grown under high oxygen tension. The enzyme catalyzes the 2-electron oxidation of ubiquinol-8 and
the 4-electron reduction of dioxygen to water. When solubilized and isolated using dodecylmaltoside, the
enzyme contains one equivalent of ubiquinone-8, bound at a high afﬁnity site (QH). The quinone bound at
the QH site can form a stable semiquinone, and the amino acid residues which hydrogen bond to the
semiquinone have been identiﬁed. In the current work, it is shown that the tightly bound ubiquinone-8 at
the QH site is not displaced by ubiquinol-1 even during enzyme turnover. Furthermore, the presence of high
afﬁnity inhibitors, HQNO and aurachin C1–10, does not displace ubiquinone-8 from the QH site. The data
clearly support the existence of a second binding site for ubiquinone, the QL site, which can rapidly exchange
with the substrate pool. HQNO is shown to bind to a single site on the enzyme and to prevent formation of
the stable ubisemiquinone, though without displacing the bound quinone. Inhibition of the steady state
kinetics of the enzyme indicates that aurachin C1–10 may compete for binding with quinol at the QL site
while, at the same time, preventing formation of the ubisemiquinone at the QH site. It is suggested that the
two quinone binding sites may be adjacent to each other or partially overlap.y, University of Illinois, 600 S.
3 9075; fax: +1 217 244 3186.
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Cytochrome bo3 is the predominant respiratory oxidase present in
Escherichia coli when grown under conditions of high aeration [1–3].
This enzyme is a member of the heme-copper superfamily [4,5],
which includes both oxygen reductases as well as NO reductases. The
oxygen reductases are of particular interest because these enzymes
couple the redox chemistry to pumping protons across the membrane
bilayer and generate a proton motive force.
Cytochrome bo3 is in a sub-family of respiratory oxidases that
directly catalyze the 2-electron oxidation of quinol within the mem-
brane instead of the 1-electron oxidation of a soluble or membrane-
bound cytochrome c. Cytochrome bo3 has one copy each of 4 subunits.
Subunits I, II and III are homologous to the mitochondrial encoded
subunits of the eukaryotic (mitochondrial) cytochrome c oxidase [6].
Whereas, in the mitochondrial oxidase subunit II contains the docking
site of the cytochrome c substrate and the CuA redox center, neither ofthese features is present in the homologous subunit II of the quinol
oxidases [7,8]. The absence of the residues required for copper ligation
to CuA is diagnostic of quinol oxidases and allows one to identify
quinol oxidases in genome sequences. Phylogenetic analysis (manu-
script in preparation) shows that cytochrome bo3 and related quinol
oxidases are derived from the cytochrome c oxidases, so the CuA site
can be considered to have been “lost.” In place of the CuA site, the
quinol oxidases have acquired one or more sites for quinol oxidation.
In the case of cytochrome bo3 from E. coli, the substrate is ubiquinol-8,
which is conﬁned to the cytoplasmic membrane. Closely related
enzymes include the aa3-600 menaquinol oxidase from Bacillus
subtilis [9,10].
Puriﬁed cytochrome bo3 can be isolated with 0, 1 or 2 ubiquinones
co-purifying with the enzyme, depending upon the detergent used
and the preparative protocol [11,12]. This was the ﬁrst indication that
the enzyme may have more than one Q-binding site [11]. The effects
of various inhibitors on the steady state kinetics of the enzyme have
provided further evidence that there must be more than one Q-
binding site [11,13,14], and the data have been interpreted in terms
of two sites (QL or QH) with the inhibitors binding to one or the other
Q-binding sites. The reactivity of the enzyme with synthetic qui-
none analogues has also been examined, showing the roles of the
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kinetic parameters [15,16].
Cytochrome bo3 that is co-puriﬁed with at least one equivalent of
ubiquinone exhibits a ubisemiquinone EPR signal when the solution
potential is poised near 0 mV at pH 8, or when the enzyme is partially
reduced [17,18]. At pH 8.2, the 1-electron reduction of the oxidized
ubiquinone has an Em2=15 mV and the reduction of the semiquinone
to the fully reduced dihydroubiquinol has an Em1=2.5 mV [18]. At pH
9, the stability constant for the semiquinone species is ∼10 [18]. The
protein binding site which stabilizes the semiquinone is referred to as
the high afﬁnity Q-binding site, or QH. Stabilizing the 1-electron
reduced form of the quinone is consistent with the quinone bound
at this site acting as a “converter,” which can be reduced by two
electrons and then transfer the electrons one-at-a-time to a 1-electron
acceptor, heme b [19,20]. The rate of formation of the semiquinone
upon mixing reduced ubiquinol-2 with the enzyme has been
monitored by rapid freeze-quench EPR spectroscopy, and the results
indicate that the semiquinone formed at the QH-site is an interme-
diate in the catalytic mechanism [21]. Transient formation of the
semiquinone has also been examined by pulsed radiolysis, in which
N-methylnicotinamide is used as a mediator for the one-electron
reduction of the oxidized enzyme. The semiquinone at the QH-site is
formedwithin 10 μs after pulsed radiolysis, and electron transfer from
the semiquinone to heme b follows, with a ﬁrst order rate constant of
1.5×103 s−1 [22]. Studies of the reaction of the fully reduced enzyme
with O2 have shown that electron transfer from heme b to the heme
o3/CuB binuclear center occurs with a rate of about 104 s−1 [19,23]. A
comparison of the intramolecular electron transfer events for enzyme
containing the quinone bound at the QH-site with enzyme fromwhich
the quinone has been removed (prepared in Triton X-100) also
supports the model that the tightly bound reduced quinone is capable
of rapid electron transfer to heme b [12].
The intrinsic rate of “pure” electron transfer between the two
hemes in cytochrome bo3, independent of coupled (slower) process-
es, is extremely fast (8×108 s−1) [24]. The slower rate (104 s−1)
observed in the reaction of the reduced enzyme with O2 is due to
coupled proton transfers and/or conformational changes.
The X-ray structure of cytochrome bo3 has been reported, but the
detergent used (octylglucoside) resulted in stripping away the bound
quinone, and substantial portions of the protein are not resolved
[25]. Nevertheless, this structure was used to identify a reasonable
candidate for a Q-binding site [25]. Subsequent EPR studies of site-
directed mutants provided convincing evidence that this proposed
site is the QH-site which stabilizes the observed semiquinone [26].
The residues implicated are R71, D75, H98 and Q101 [25,26].
The identity of the low afﬁnity, or QL site, has been problematic to
the extent that the existence of this site has been questioned [25].
Both the use of photo-reactive Q analogues designed to covalently
attach to the protein at the QL site [27,28], as well as the location of
inhibitor-resistant mutations [29], have been used to identify the QL
site. In each case, subunit II was implicated, which was satisfying
since the CuA site and docking site for cytochrome c in the related
cytochrome c oxidases are located within subunit II. Mutations in one
residue in subunit II, WII136A, were shown to perturb the apparent Km
of ubiquinol-1 [30]. However, closer examination of WII136A and
other speciﬁc residues suggested to be at or near the QL site [29,30]
show that they are not near the membrane interface in the
structure [25] and, therefore, are not likely to be part of a quinone
binding site. Furthermore, sequence alignments of the many quinol
oxidases (N400) presently available shows that WII136 is not fully
conserved. The residues identiﬁed by the photolabeling [28] and
inhibitor-resistance [28,29] are not near the site proposed to be the
QH site nor to any reasonable location for binding ubiquinol-8 from
within the membrane bilayer.
In the current work, new evidence is presented to conﬁrm that
cytochrome bo3 must contain two functionally distinct Q-sites. It isalso shown that the inhibitor HQNO binds stoichiometrically to the
enzyme and prevents formation of the ubisemiquinone at the QH-site,
but does not displace the ubiquinone-8 bound at the QH-site. The
inhibitor aurachin C1–10 also prevents formation of the ubisemiqui-
none at the QH-site, but appears to compete for quinol binding at the
QL-site. The possibility is considered that perhaps the QH-, QL- and
HQNO binding sites are adjacent or partially overlap, but that binding
of ubiquinone-8 at the QH-site is not eliminated by simultaneous
occupation of either the QL-site or the HQNO binding site.
2. Materials and methods
2.1. Expression and puriﬁcation of cytochrome bo3
Wild type and mutants of cytochrome bo3 were expressed and the
proteins were puriﬁed using the detergent dodecylmaltoside, as
previously described [31].
2.2. Quinone extraction and analysis
The amount of ubiquinone-8 in the puriﬁed cytochrome bo3 was
determined by quinone extraction followed by reversed phase HPLC
analysis. 10 nmol of puriﬁed enzyme, together with 10 nmol of
ubiquinone-10 (Q10), were diluted in 50 mM K2HPO4, 0.1% dodecyl-
maltoside, pH 8.3 buffer, and extracted with 3 mL of 6:4 methanol:
petroleum ether by vortexing vigorously for 1 min (3 times). The
mixture was allowed to sit for 10 min before vortexing again for an
additional min, followed by centrifuging at 1,000 rpm for 10 min. The
upper, organic layer was removed to a fresh tube, and the remaining
mixture was subjected to further extraction two more times. The
organic phase was then evaporated under a nitrogen stream, and the
dried, oily residue was re-dissolved in ethanol.
The extracted quinones were analyzed using a reversed phase
Microsorb-MV 100-5 C18 HPLC column (Varian, Palo Alto, CA) on a
Beckman System Gold HPLC system ﬁtted with a diode array detector,
and monitored at 278 nm. The mobile phase was 4:3:3 ethanol:
methanol:acetonitrile. The extracted ubiquinone-8 was quantiﬁed
from the ratio of the peak areas of ubiquinone-8 to an internal
standard, ubiquinone-10.
2.3. Preparation of quinone-free cytochrome bo3
Puriﬁed cytochrome bo3 in dodecylmaltoside (0.1%) was diluted at
least 50-fold in buffer containing 50 mM K2HPO4, 0.1% Triton X-100
(Anatrace), pH 8.3, and then incubated for several hours with Ni-NTA
resin with gentle stirring at 4 °C. The resin (with bound enzyme) was
then loaded onto a column and washed with several column volumes
of 50 mM K2HPO4, 0.1% Triton X-100, pH 8.3, followed by 50 mM
K2HPO4, 0.1% dodecylmaltoside, pH 8.3. The protein was then eluted
with the same buffer plus 100 mM imidazole. The eluted protein was
pooled, concentrated, and dialyzed against 50 mM K2HPO4, 10 mM
EDTA, 5% glycerol, 0.1% dodecylmaltoside, pH 8.3, and then ﬂash-
frozen in liquid nitrogen and stored at −80 °C.
2.4. Steady-state enzymatic activity assays
The steady state oxygen reductase activity of cytochrome bo3 was
measured using two different methods.
2.4.1. Method I: oxygen electrode
Oxygen concentration wasmonitored using a YSI model 53 oxygen
electrode (Yellow Springs Instrument Co., Yellow Springs, OH)
equipped with a temperature-controlled 1.8-mL electrode chamber
at 37 °C. The reaction mixture for this assay consisted of 50 mM
K2HPO4, 0.1% DM, 2 mM dithiothreitol and 200 μM ubiquinone-1, pH
7.0. The concentration of oxygen in the air-saturated buffer at this
Fig. 1. Schematic illustrating the 1-site and 2-site models for quinone binding to
cytochrome bo3.
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initiated by injecting a few microliters of diluted enzyme.
2.4.2. Method II: coupled enzyme assay
To determine the enzyme velocity as a function of the concentra-
tion of ubiquinol-1, it was advantageous to use a coupled enzyme
assay that maintained the concentration of ubiquinol-1 constant. This
was accomplished by using rat liver DT-diaphorase (kindly provided
by Professor Gary Cecchini at the University of California, San
Francisco), with NADH as the reductant. The reaction mixture for
this assay consisted of 160 μMNADHand 20–80 μg/mLDT-diaphorase,
and the reaction was followed by the decrease in absorption at
340 nm (oxidation of NADH) after the addition of cytochrome bo3 at
25 °C.
2.5. Re-isolation of cytochrome bo3 after turnover with ubiquinol-1
In order to determine if ubiquinol-8 bound at the QH-site was
displaced during enzyme turnover with ubiquinol-1 the following
procedure was used. Puriﬁed cytochrome bo3 (5 mg), isolated in
dodecylmaltoside, was diluted into 5 mL of 50 mM K2HPO4 buffer, pH
8.3, containing 0.1% dodecylmaltoside, 10.5 mM dithiothreitol and
1.05 mM ubiquinol-1 at 37 °C. The reaction mixture was incubated
at 37 °C for 10 min, and then loaded onto a column containing the Ni-
NTA resin (QIAGEN) pre-equilibrated with 50 mM K2HPO4, 0.1%
dodecylmaltoside, pH 8.3. The Ni-NTA resin with bound cytochrome
bo3 was washed with buffer containing 50 mM K2HPO4, 0.1%
dodecylmaltoside at pH 8.3, until the excess ubiquinone-1 was
removed (monitored by the absorbance at 275 nm). The bound
cytochrome bo3 was eluted with the same buffer plus 100 mM
imidazole, and then concentrated and dialyzed to remove the
imidazole. The content of ubiquinone-8 was then determined as
described above.
An alternative procedure was also used in which the enzyme was
ﬁrst bound to the Ni-NTA column and was washed by buffer
containing dithiothreitol and ubiquinol-1. Any displaced ubiquinol-
8 would be expected to be swept away by the buffer. Both procedures
yielded the same results.
Variations of the same procedure were used to quantify the
displacement of ubiquinone-8 after incubation in the presence of the
inhibitors HQNO and AC1-10.
2.6. EPR spectroscopy
The CW EPR measurements were performed on an X-band Varian
EPR-E122 spectrometer. Methods used for preparing samples and
obtaining EPR spectra have been previously described [31,32].
2.7. HQNO binding monitored by ﬂuorescence anisotropy
HQNO in water ﬂuoresces with an emission maximum at 480 nm,
but when bound to proteins the ﬂuorescence is often completely
quenched. Examples are the cytochrome bc1 complex [33], fumarate
reductase [34–36], nitrate reductase [37,38] and dimethylsulfoxide
reductase [39]. However, attempts to monitor HQNO by changes in
the ﬂuorescence intensity revealed that the ﬂuorescence of HQNO is
not quenched upon binding to cytochrome bo3. For this reason, the
binding of HQNO to cytochrome bo3 was monitored by the change in
the ﬂuorescence anisotropy of the emission from HQNO, using a
Varian Cary EclipseTM ﬂuorescence spectrophotometer (Varian, Palo
Alto, CA) ﬁtted with automated polarizers. The anisotropy is deﬁned
in terms of the ratio of the intensity of light emitted parallel and
perpendicular to the plane of polarization of the incident beam.
anisotropy =
I∥−I⊥
I∥ + 2I⊥The titration was performed by increasing the enzyme concentra-
tion with a ﬁxed concentration of HQNO to avoid problems of HQNO
aggregation and to limit the amount of ethanol (used to prepare the
stock solution of HQNO) which caused the protein to precipitate.
Cytochrome bo3 was titrated in 1–4 μL aliquots from a stock solution
into 50 mM K2HPO4, 0.1% dodecylmaltoside, pH 8.3 buffer containing
1 μMHQNO. The excitation wavelength was 341 nm and the emission
wavelength was 480 nm. As a control, enzyme was titrated into buffer
in the absence of HQNO. The data were ﬁt with a model assuming
independent binding sites.
2.8. Synthesis of aurachin C1–10
The inhibitor aurachin C1–10 was synthesized based on a protocol
described previously [40]. The most important modiﬁcation was that
the order of the ﬁrst two steps of the 7-step synthesis was reversed.
The methylation of crotonate was followed by the condensation of
aniline and 3-methylcrotonate instead of carrying out the condensa-
tion of aniline and crotonate followed by methylation of 3-
anilinocrotonate.
3. Results
3.1. One or two Q-binding sites?
The main argument supporting a two-site model is that the
quinone at the QH-site does not exchange with exogenous ubiqui-
none-8 and, once removed, is difﬁcult to replace the ubiquinone-
8 [11,12]. This is consistent with the idea that the QH site cannot
function as a catalytic site, which demands rapid exchange during
catalytic turnover. It is noted that the bc1 complex is isolated with
tightly bound quinones at the Qo and Qi sites but, under turnover
conditions, both sites are involved in catalysis with rapid binding of
substrate and release of products [41].
To provide a more convincing test for the existence of the QL-site,
the ability to exchange the bound ubiquinone-8 for exogenous
quinone was examined under turnover conditions with ubiquinol-1.
Fig. 1 illustrates the two models to be distinguished. The one-site
model assumes that the quinone bound at the high afﬁnity site can
readily exchange under conditions of catalytic turnover and, there-
fore, is the only site required. The two-site model assumes that
Fig. 2. Structures of quinone substrates and quinone-like inhibitors referred to in the
text.
Fig. 3. HPLC elution proﬁles following extraction of ubiquinone-8 from puriﬁed
cytochrome bo3. A known amount of ubiquinone-10 is included in each sample as an
internal standard. Panel A: enzyme isolated in dodecylmaltoside (DM) contains 1
equivalent of ubiquinone-8, whereas enzyme washed with Triton X-100 has no bound
ubiquinone-8. Panel B: enzyme incubated with oxidized ubiquinone-1 (500 μM) retains
bound ubiquinone-8 (top), as does enzymewhich has been incubated under conditions
of catalytic turnover with ubiquinol-1 (see text).
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are transferred, presumably in a two-electron transfer to the
quinone at the QH-site. In order to distinguish between these two
alternatives, the enzyme with one equivalent of bound ubiquinone-
8 was allowed to incubate under aerobic conditions with reduced
ubiquinol-1, a soluble analogue of the natural substrate, ubiquinol-
8 (see Fig. 2). The incubation time was sufﬁcient to allow multiple
turnovers of ubiquinol-1. If the one-site model is correct, then
multiple turnovers with ubiquinol-1 must displace the initially
bound ubiquinol-8, which would become diluted into the detergent
micelles. To determine whether the bound ubiquinone-8 had been
displaced, the His-tagged enzyme was bound to the Ni-NTA column
and extensively washed with buffer to remove free or weakly
bound quinone. After elution of the enzyme, the quinone was
extracted and quantiﬁed by HPLC analysis. The results (Fig. 3B)
show that the ubiquinone-8 remained bound to the enzyme with
the same stoichiometry as measured prior to the turnover with
ubiquinol-1. The same experiment was done by allowing the
enzyme to turnover with ubiquinol-1 while bound to the Ni-NTA
column, during which buffer was continuously ﬂowing. The results
were identical. As a control, the enzyme was washed with Triton X-
100 detergent to remove the quinone, and the quinone content
determined by HPLC analysis (Fig. 3A). The data support the two Q-
site model.
3.2. Binding of HQNO to cytochrome bo3
It has been shown previously that HQNO (Fig. 2) is an effective
inhibitor of cytochrome bo3 [13,20]. Fig. 4A shows the inhibition of
cytochrome bo3 (with ubiquinone-8 bound to the QH site) by HQNO
using the coupled assay to maintain the ubiquinol-1 substrate
reduced. The Ki is 0.74 μM. Fig. 4B shows a double-reciprocal plot,
indicating a pattern of inhibition that is noncompetitive, con-
sistent with previous reports [13,20]. The noncompetitive inhibi-
tion pattern suggests that HQNO does not bind to the substrate (QL)
binding site.
To extend these observations, the stoichiometry and binding
afﬁnity of HQNO to the enzyme were measured directly by
ﬂuorescence spectroscopy. HQNO is itself ﬂuorescent, and the
ﬂuorescence is often quenched upon binding to proteins. However,
upon binding to cytochrome bo3, the ﬂuorescence intensity is not
substantially perturbed. Therefore, binding was monitored by
measuring the ﬂuorescence anisotropy, which increases substan-
tially when HQNO binds to the enzyme. In order to avoid artifacts
due to the aggregation of HQNO at high concentrations, the
titration was performed by maintaining the total concentration of
HQNO constant while increasing the amount of the protein. Arepresentative binding isotherm is shown in Fig. 5. Fitting the data
to a model, assuming independent sites, yields a best ﬁt of 1.1 sites
and a Kd of 4.0 μM. The reason why the kinetic inhibition constant
and the dissociation constant are different by about a factor of 5
is not clear, but may be due to differences in assay conditions or
enzyme preparation. The main point is that the data show that
HQNO binds to a single site on cytochrome bo3. The experiment
was repeated in the presence of a large excess of oxidized
ubiquinol-1 (Table 1) and the same result was obtained, suggesting
that at least the oxidized form of ubiquinol-1 does not compete for
binding at the same site.
Fig. 4. Inhibition of steady state ubiquinol-1 oxidase activity by HQNO. Panel (A) is a
direct plot of the data, and Panel (B) is a Lineweaver–Burke plot showing non-
competitive inhibition.
Fig. 5.HQNO binding to cytochrome bo3 which has been isolated with one equivalent of
ubiquinone-8 bound to the QH-site. Binding is monitored by ﬂuorescence anisotropy,
titrating the enzyme into a solution containing 1 μM HQNO. The points are
experimental data and the line is a ﬁt to 1 binding site with a Kd of 4 μM.
Table 1
Characterization of wild type and mutants of cytochrome bo3. Shown are the steady
state kinetic parameters for ubiquinol-1 oxidase activity (Vmax and KM); the dissociation
constant for HQNO determined by ﬂuorescence anisotropy titration; and the
concentration of AC1–10 required for 50% inhibition of ubiquinol-1 oxidase activity
(Ki).
Cytochrome bo3 Relative Vmax
(%)
KM UQ1H2
(μM)
Kd HQNO
(μM)
Ki AC1–10
(nM)
wild type 100 53 4.0 15
wild type+ 300 μM Q1 – – 4.1 –
wild type
+ 1500 μM Q1
– – 6.8 –
wild type (no bound Q8) – – 5.8 –
D188A 69 56 5.0 25
D188N 71 52 4.0 ND
R257Q 47 60 4.0 12
WII136A 75 63 4.1 23
H98S - - 3.6 -
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of HQNO, the EPR signal of the pre-formed semiquinone at the QH-site
is inhibited [18]. Fig. 6A shows that the presence of an excess of HQNO
prevents formation of the semiquinone. If HQNO were binding at the
QH site, it would displace the tightly bound ubiquinone-8. However,
this does not occur. The enzyme was bound to the Ni-NTA column in
the presence of HQNO and then washed with several column volumes
of buffer containing HQNO. Following this, the enzymewas eluted and
the quinone was extracted and quantiﬁed. Cytochrome bo3 retains
one equivalent of ubiquinone-8 in the presence of HQNO (Fig. 6B).Fig. 6. (A) EPR spectrum of the semiquinone formed by ubiquinone-8 bound at the QH-
site of wild type cytochrome bo3. The presence of a 5-fold excess of HQNO prevents
formation of the semiquinone. (B) HPLC elution proﬁle of the ubiquinone-8 extracted
from enzyme incubated under the same conditions as used for the EPR experiment in
the top panel. The data show approximately 1 equivalent of ubiquinone-8 remains
bound to the enzyme, unchanged from prior to the addition of HQNO.
Fig. 7. Inhibition of cytochrome bo3 by AC1-10. (A) A double reciprocal plot of (enzyme
velocity)−1 vs. (ubiquinol−1 concentration)−1 showing competitive inhibition. (B) EPR
spectrum of the semiquinone formed by ubiquinone-8 bound at the QH-site of wild type
cytochrome bo3. The presence of a 5-fold excess of AC1–10 prevents formation of the
semiquinone. (C) HPLC proﬁle showing the ubiquinone-8 remains bound to cytochrome
bo3 in the presence of AC1–10. The ubiquinone-10 is an internal standard used to
quantify the amount of ubiquinone-8 extracted from the enzyme.
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ubiquinone-8 had been removed was also examined. The results
(Table 1) show one HQNO binds with a Kd=5.8 μM, similar to the
data obtained with enzyme containing ubiquinone-8 bound at the QH
site.3.3. The binding of AC1-10 to cytochrome bo3
Previous work has shown that aurachin C and analogues are potent
inhibitors of cytochrome bo3 [40,42]. The inhibition of ubiquinol-1
oxidase activity by AC1–10 [40] is shown in Fig. 7. The Ki was
determined to be about 15 nM, and the pattern of inhibition (Fig. 7A)
indicates that AC1–10 is a competitive inhibitor. Previous work
concluded that aurachin C binds to one site on cytochrome bo3 [42].
Incubation of a 50 μM solution of cytochrome bo3 with a 5-fold excess
of AC1–10 prevents formation of the semiquinone EPR signal (Fig. 7B)
but, as was the case with HQNO, the tightly bound ubiquinone-8 is not
displaced from the QH site (Fig. 7C).
3.3.1. Site-directed mutagenesis of D188, R257 and WII136
The location of the QL-site is not known. It is a reasonable
assumption that residues that directly interact with ubiquinol at the
QL-site will be conserved among the many ubiquinol oxidases.
Residues that are conserved include R71, D75, M78 and H98, which
are proposed to constitute the QH-site. Two additional residues in
subunit I that are conserved in all the quinol oxidases are D188 and
R257. These residues are located near each other on the surface of
subunit I at a level expected to be within the membrane bilayer and
reasonably close to the QH-site. Hence, mutants were made to test
whether these residues might be part of the QL site: D188A, D188N
and R257Q. The results are summarized in Table 1, along with data
fromWII136A. In each case, the enzymes were puriﬁed and examined
using (1) ubiquinol-1 oxidase activity (Vmax), including the KM of
ubiquinol-1; (2) HQNO binding, measured by ﬂuorescence anisotro-
py; and (3) inhibition of ubiquinol-1 oxidase activity by AC1–10.
Although there is a modest loss of activity due to each mutation, there
is no indication that either the QL quinol binding site, or the HQNO
binding site, or the AC1–10 binding site involves these residues. It is
noted that both D188 and R257 are also present inmany cytochrome c
oxidases, indicating a function other than quinol binding. One unusual
observation is that neither the D188A nor R257Q mutant oxidases
were able to support aerobic growth when expressed in a strain of
E. coli without a genomically encoded respiratory oxidase. However,
the isolated proteins were active (Table 1).
3.4. Additional mutations at the QH-site
A number of mutations at the QH-site (R71, D75, H98 and Q101)
have been described [25,26]. In those cases where measurements
were made, it was shown that these mutations do not reduce the
amount of bound ubiquinone [25]. Table 2 shows result obtained with
a number of additional mutations at the QH-site. The EPR spectros-
copy of the D75E and D75H mutants has been previously reported
[32]. Besides the conservative replacement D75E, all of the other
mutants have very low or no quinol oxidase activity. Apart from D75E,
D75H and D75N, the semiquinone is also not formed. Table 2 shows
that none of these mutations result in loss of the tightly bound
ubiquinone-8 from the QH-site. This is also true for the double
mutation, R71D/D75R, in which the aspartate and arginine have been
switched.
For one mutation at the QH-site, H98S, the binding of HQNO was
also examined. The results (Table 1) show that the dissociation
constant is essentially the same as for the wild type enzyme,
indicating that this residue is not important for the afﬁnity of HQNO
to the enzyme.
3.5. Generating the semiquinone radical at the QH site using ascorbate
The semiquinone form of ubiquinone-8 bound at the QH site can be
generated by using ascorbate as a reducing agent and, after an
empirically determined time, freezing the partially reduced (mixed
valence) enzyme [31,32,43–45]. The continuous wave X-band EPR
Table 2
Characterization of mutants at the QH-site of cytochrome bo3. Shown are the relative
ubiquinol-1 oxidase activity, the content of ubiquinol-8 and whether the semiquinone
is formed upon partial reduction by ascorbate.
Cytochrome
bo3
Relative activity
(%)
Quinone content
(Q8/enzyme)
Semiquinone
formation
wild type 100 1.1 Yes
D75E 135 1.2 Yes
D75H 4 0.9 Yes
D75N ∼0 1.3 Yes
D75R ∼0 1.2 No
R71D ∼0 1.4 No
R71K ∼0 1.3 No
R71Q ∼0 1.3 No
H98N 1 1.4 No
H98S 2 1.4 No
H98T 1 1.5 No
Q101N 5 1.3 No
R71D/D75R ∼0 1.3 No
Fig. 9. Behavior of the EPR intensities of the semiquinone, heme o3 and heme b as a
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enzyme are shown in Fig. 8A. The spectra show features previouslyFig. 8. (A) Continuous-wave X-band EPR spectrum of oxidized (red) and reduced
(black) cytochrome bo3 (see text for details). (B) EPR spectra of the reduced D75E and
D75H mutants. Temperature 15 K, microwave power ∼10 mW, modulation amplitude
0.5 mT, reduction time 6 h.
function of reduction time. The peak height of each sample in the spectrum recorded at
1 h is arbitrarily set to a value of 1, and relative intensities are plotted as a function of
time. The amplitudes of the signals due to ferric heme o3 (g=5.81) and ferric heme b
(g=2.26) were measured from the spectra recorded at 15 K. The amplitude of the
semiquinone signal was measured at 90 K with low microwave power to avoid
saturation conditions and signiﬁcant overlap with other signals around g∼2. The
relative intensities of the heme b, heme o3 and semiquinone signals are not necessarily
proportional to the relative concentrations of the three species.assigned [46,47] to high spin heme o3 (g=5.81) and low spin heme b
(g=2.98, 2.26 and 1.45) as well as the signal from the semiquinone
radical (g=2). As previously discussed, the signal from the high spin
heme o3 (g=5.81) is due to a small fraction of the heme (≈ 5% to
10%) which is no longer coupled to CuB [46,47]. The spectra of the
partially reduced forms of twomutants in the QH site, D75E and D75H,
are also shown in Fig. 8B. The D75E mutant is catalytically active and
the EPR spectrum is similar to that of the wild type oxidase. The D75H
mutant is catalytically inactive, and the EPR spectrum of the partially
reduced enzyme lacks the signals from the low spin heme b,
indicating that heme b in this mutant is completely reduced by the
ascorbate.
The peak intensities of the EPR features for the wild type oxidase
as a function of time after the addition of ascorbate are shown in
Fig. 9. The intensity of the low spin heme b signal decreases with
time. In contrast, the amplitude of the high spin heme o3 signal as
well as the amplitude of the semiquinone signal increase in parallel,
reaching a maximum at about 6 hr. The simplest explanation is
that the amount of reduced CuB (revealing the EPR signal from
the oxidized heme o3) varies in proportion to the amount of
semiquinone present. In the D75H mutant, the reduction of heme b
occurs substantially more rapidly than in either the wild type or
D75E mutant oxidase. As a result, after 6 hours, the EPR signal from
heme b is not observed.
4. Discussion
The motivation of the current work was primarily to test the
validity of the two-site model of ubiquinone binding to cytochrome
bo3. It was previously shown that a large excess of ubiquinone-1 does
not displace the bound ubiquinone-8 under conditions when all the
species remain oxidized [11], and this has been repeated (Fig. 3). The
critical test, however, is to examine displacement under conditions
when the enzyme is turning over ubiquinol-1. The fact that ubiquinol-
1 does not displace ubiquinol-8 at the QH site under turnover
conditions clearly shows that ubiquinone-8 at this site does not
readily exchange. These new data deﬁnitively demonstrate that there
1931L.L. Yap et al. / Biochimica et Biophysica Acta 1797 (2010) 1924–1932must bemore than one quinone binding site, thus supporting the two-
site model (Fig. 1) [11].
Arguments for the two-site model based on the effect of inhibitors
on steady state kinetics [13,14] have assumed that some of the
inhibitors, including HQNO, can bind to the QH-site. However, data
presented in this paper as well as previously published data [11] show
that HQNO does not displace the ubiquinone-8 at the QH-site. New
data in the current work show, in addition, that only one equivalent of
HQNO binds to the enzyme, and that the afﬁnity is not signiﬁcantly
altered by removing the tightly bound ubiquinone-8 at the QH-site.
Most of the information about the interaction of ubiquinone at the
QH-site is from EPR studies of the stabilized ubisemiquinone that
forms at this site [26,31,32,45]. Data in Figs. 8 and 9 show the full EPR
spectrum of the enzyme and the changes that occur during the partial
reduction by ascorbate. Under the conditions utilized, the reduction of
the wild type enzyme by ascorbate is slow (hours) and, in addition to
formation of the ubisemiquinone, heme b and CuB are partially
reduced in the ﬁnal product.
HQNO also prevents the formation of the ubisemiquinone at the
QH-site when the enzyme is partially reduced. This is shown in the
present work, and was reported previously [18]. The addition of
HQNO to the fully reduced enzyme also prevents the oxidation of
ubiquinol-8 at the QH-site by O2 [48]. Hence, HQNO functionally
disrupts the reactions of the ubiquinone at the QH-site, though this
quinone is not displaced from the enzyme. One possibility, previously
discussed [13], is that the ubiquinone-8 bound at the QH-site is held in
place primarily by interactions with the hydrophobic isoprene side
chain. Therefore, inhibitors such as HQNO can displace the quinone
ring without displacing the molecule as a whole. This would be
consistent with the observation that the mutations at the QH-site
which eliminate catalytic activity as well as prevent formation of the
semiquinone species, retain the bound ubiquinone-8, shown in
Table 2 as well as in previous work [26,48]. Arguing against this
interpretation is the fact that the dissociation constant of HQNO to the
enzyme is only slightly increased (4.0 μM to 5.8 μM) by removal of the
ubiquinone-8 from the QH-site (Table 1). If HQNOwere competing for
the same site with a locally tethered head group of ubiquinone-8, one
would expect a larger effect on the Kd of HQNO by the presence of the
bound ubiquinone-8. Nevertheless, the competition between HQNO
and ubiquinone-8 for binding to the QH-site needs to be examined
under conditions where the enzyme is partially or fully reduced to
further test this model. What can deﬁnitely be concluded at this point
is that H98, although part of the QH-site, does not interact with HQNO,
as shown by the fact that the H98S mutant has the same afﬁnity for
HQNO as does the wild type (Table 2).
The current work strongly supports the model that cytochrome
bo3 contains two quinone binding sites, QH and QL. The interactions
critical for the high afﬁnity of the tightly bound quinone at the QH-site
remain unknown, sincemutations of residues at the QH-site which are
known to interact with the ubisemiquinone ring [31,32,45] do not
physically eliminate the bound quinone (Table 2).
The location of the QL site is also not known. It is likely that the QL-
site is adjacent to the QH-site. This would be consistent with the fact
that AC1–10, which is a competitive inhibitor for the QL-site, also
perturbs the QH-site, evidenced by blocking the formation of the
ubisemiquinone at the QH-site upon reduction by ascorbate. It cannot
be excluded that some of the residues involved at the QH-site are also
involved in the QL-site.
Further examination of HQNO binding to mutants should be
helpful to identify the HQNO binding site, which appears to be
separate from both the QH-site and the QL-site. The possibility that the
ubiquinone-8 bound at the QH-site is tethered by the hydrophobic
side chain and has several modes of interaction between the quinone
ring and the protein, depending on the redox state, should be
seriously considered. In this model, HQNO could displace the
ubiquinone head group at the QH-site without actually displacingthe bound quinone. This would be consistent with the fact that no
mutants have been found yet which increase the KM for ubiquinol-1,
since such mutations would also alter the QH-site and eliminate
catalytic function. Clearly, further work is required.
5. Conclusions
It is deﬁnitively demonstrated that cytochrome bo3 must have two
ubiquinone binding sites. Ubiquinone-8 bound at the QH-site acts as a
cofactor and is not displaced during enzyme turnover, nor in the
presence of the inhibitors HQNO or AC1–10. AC1–10 appears to
compete for ubiquinol-1 binding at the QL-site, which is the substrate
binding site. HQNO binds stoichiometrically to one site, but is a
noncompetitive inhibitor at the QL site. The QH-site, QL-site and the
HQNO binding site are likely to be adjacent and may be partially
overlapping.
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